Protein modifications as potential biomarkers in breast cancer
- PMID: 20072669
- PMCID: PMC2805424
- DOI: 10.4137/bmi.s2557
Protein modifications as potential biomarkers in breast cancer
Abstract
A variety of post-translational protein modifications (PTMs) are known to be altered as a result of cancer development. Thus, these PTMs are potentially useful biomarkers for breast cancer. Mass spectrometry, antibody microarrays and immunohistochemistry techniques have shown promise for identifying changes in PTMs. In this review, we summarize the current literature on PTMs identified in the plasma and tumor tissue of breast-cancer patients or in breast cell lines. We also discuss some of the analytical techniques currently being used to evaluate PTMs.
Keywords: PTMs; biomarkers; breast cancer; post-translational modifications.
Similar articles
-
The Exposure to Human Breast Cancer Cells Altered 14 Post-Translational Modifications of Human Serum Albumin.EJIFCC. 2022 Dec 12;33(4):295-308. eCollection 2022 Dec. EJIFCC. 2022. PMID: 36605305 Free PMC article.
-
Exploring the Role of Unconventional Post-Translational Modifications in Cancer Diagnostics and Therapy.Curr Protein Pept Sci. 2024;25(10):780-796. doi: 10.2174/0113892037274615240528113148. Curr Protein Pept Sci. 2024. PMID: 38910429 Review.
-
Histone proteomics reveals novel post-translational modifications in breast cancer.Aging (Albany NY). 2019 Dec 8;11(23):11722-11755. doi: 10.18632/aging.102577. Epub 2019 Dec 8. Aging (Albany NY). 2019. PMID: 31816600 Free PMC article.
-
Modifications in the cellular proteome and their clinical application.Medicina (B Aires). 2019;79(Spec 6/1):570-575. Medicina (B Aires). 2019. PMID: 31864228 Review. English.
-
Mass spectrometric analysis of high-mobility group proteins and their post-translational modifications in normal and cancerous human breast tissues.J Proteome Res. 2007 Jun;6(6):2304-14. doi: 10.1021/pr070072q. Epub 2007 Apr 25. J Proteome Res. 2007. PMID: 17455969
Cited by
-
Dance of The Golgi: Understanding Golgi Dynamics in Cancer Metastasis.Cells. 2022 Apr 28;11(9):1484. doi: 10.3390/cells11091484. Cells. 2022. PMID: 35563790 Free PMC article. Review.
-
Autoantibodies in Early Detection of Breast Cancer.Cancer Epidemiol Biomarkers Prev. 2020 Dec;29(12):2475-2485. doi: 10.1158/1055-9965.EPI-20-0331. Epub 2020 Sep 29. Cancer Epidemiol Biomarkers Prev. 2020. PMID: 32994341 Free PMC article.
-
Label-Free and Real-Time Detection of Protein Ubiquitination with a Biological Nanopore.ACS Nano. 2017 May 23;11(5):4387-4394. doi: 10.1021/acsnano.6b07760. Epub 2017 Mar 29. ACS Nano. 2017. PMID: 28353339 Free PMC article.
-
Binding of circulating autoantibodies in breast cancer to native and peroxynitrite-modified RNA.J Zhejiang Univ Sci B. 2013 Jan;14(1):40-6. doi: 10.1631/jzus.B1200015. J Zhejiang Univ Sci B. 2013. PMID: 23303630 Free PMC article.
-
Ferrochelatase: Mapping the Intersection of Iron and Porphyrin Metabolism in the Mitochondria.Front Cell Dev Biol. 2022 May 12;10:894591. doi: 10.3389/fcell.2022.894591. eCollection 2022. Front Cell Dev Biol. 2022. PMID: 35646904 Free PMC article. Review.
References
-
- Hoffman MD, Sniatynski MJ, Kast J. Current approaches for global post-translational modification discovery and mass spectrometric analysis. Anal Chim Acta. 2008 Oct 3;627(1):50–61. - PubMed
-
- Krueger KE, Srivastava S. Posttranslational protein modifications: current implications for cancer detection, prevention, and therapeutics. Mol Cell Proteomics. 2006 Oct;5(10):1799–810. - PubMed
-
- Hanash SM, Pitteri SJ, Faca VM. Mining the plasma proteome for cancer biomarkers. Nature. 2008 Apr 3;452(7187):571–9. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous